Whitney Taylor is a veteran journalist and regular contributor at Injury Lawyer News. Whitney is particularly interested in the impact of the pharmaceutical products impacting women such as birth control products, transvaginal mesh products, and others.
The FDA has reclassified transvaginal mesh used for treating pelvic organ prolapse or POP to indicate the risks associated with the product. Now categorized as a high-risk device, the agency is also requiring manufacturers to prove their products are both safe and effective. The new... Read More
A couple has filed a lawsuit involving a power morcellator, alleging the device led to the spread of a potentially deadly uterine cancer in the wife. The couple further asserts that the manufacturer of this device, Storz America, failed to provide proper warning about the... Read More
Another study has found a compelling association between use of antidepressants during pregnancy and autism in children born to those women. The study found that women who used these drugs during the second half of their pregnancies increased the risk that their unborn children would eventually... Read More
The judge overseeing coordinated litigation involving testosterone replacement products has set a schedule for early trials to begin in early 2017. Currently, the coordinated proceedings involve nearly 3,500 complaints filed by men that allege use of testosterone led to serious side effects like heart attack,... Read More
Coordinated proceedings involving talcum powder litigation continues to move forward in New Jersey, even as the number of lawsuits continues to increase. Lawsuits were consolidated by court order just weeks ago and now the first status conference has been scheduled to discuss the details of... Read More
A Maryland task force has recommended that the state implements a no-fault birth injury fund to compensate families with children who suffered serious trauma during delivery. While proponents of the fund claim it will help more injured children and their parents receive financial assistance to get... Read More
A plaintiff has filed a lawsuit in Louisiana, alleging use of Zofran during pregnancy led to birth defects in her newborn son. The complaint joins dozens of others filed against Zofran manufacturer GlaxoSmithKline, most of which are now coordinated in multidistrict litigation in U.S. District... Read More
As hundreds of plaintiffs await their day in court, the coordinated litigation involving Fresenius dialysis products Granuflo and Naturalyte continues to move forward. Last week, the judge overseeing the proceedings and parties involved in the litigation reviewed preparation of early trials that could provide insight... Read More
